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ated with SSI risk. Logistic regression models with ROC curve analysis were used 
for the development of a risk-index tool for SSI. Results: Male gender (OR= 1.854, 
p= 0.005), inpatient status (OR= 9.491, p< 0.001), hypertension (OR= 2.464, p< 0.001), 
corticosteroid use (OR= 2.485, p= 0.042) and partial or total dependence for everyday 
activities prior to surgery (OR= 2.577, p= 0.047) were independent predictors for SSI 
and were included in the SSI-risk tool. The SSI-risk tool has a range from 0 to 100. 
Scores below 43.17, between 43.17 and 63.40 and above 63.40 represent a low, moder-
ate and high risk for SSI development, respectively. Compared to low-risk patients, 
moderate-risk patients had a relative risk of 3.963 (95% CI= 2.58-6.08, p< 0.001) and 
high-risk patients had a relative risk of 6.48 (95% CI= 4.16-10.10, p< 0.001) of develop-
ing an SSI. Overall, 3% of low-risk patients, 10% of moderate-risk patients and 16% 
of high-risk patients developed an SSI. ConClusions: In this study, a simple risk 
tool for quantifying SSI risk was developed. The tool has been validated for the JGH 
population. Further validation in other populations will be conducted.
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objeCtives: FRAX reliably predicts 10-year fracture risk for adults in the 
general population. However, its utility for HIV-infected adults has not been 
assessed. Methods: Using dual energy X-ray absorptiometry (DEXA) BMD values 
of the left femoral neck and clinical data collected prospectively during 2004-2012 
from two CDC-sponsored HIV cohorts, we calculated the initial FRAX 10-year risk 
of a major osteoporotic fracture (MOF) (i.e., of the hip, spine, forearm, or shoulder), 
assessed rates of any new bone fracture and MOF per 100 person-years (100py) 
of follow-up stratified by initial FRAX-score intervals, and used Cox proportional 
hazards models to identify risk factors for new fractures. Results: Among 1006 
participants, 83% were male, 67% were non-Hispanic white, median age was 42 
years, median CD4+ cell count was 408 cells/mm3, median BMD was 0.90 g/cm2, 
and median FRAX score was 1.9; FRAX scores were higher for those with subse-
quent fracture vs. those without (p< 0.01). During observation after initial DEXA, 95 
participants (9.4%) had a new fracture: 7.1% occurred among persons with FRAX 
score < 3% (1.39/100py); 15.3% among persons with FRAX score ≥ 3% (3.27/100py). 
MOF occurred among 1.5% of persons with FRAX score < 3% (0.30/100py) and 4.9% 
of persons with FRAX score ≥ 3% (1.04/100py). In multivariate analyses, having prior 
fracture (adjusted hazard ratio [aHR] 2.02, 95% confidence interval [CI]: 1.09-3.71), 
older age (aHR 1.30 per 10 years, CI: 1.04-1.62), and lower BMD (aHR 0.14 per g/cm2, CI: 
0.03-0.59) were associated with risk of any new fracture. In a separate model, having 
FRAX score ≥ 3% vs. FRAX of < 3.0% was associated with any new fracture (HR 2.31, 
CI: 1.54-3.46). ConClusions: In a large convenience sample of relatively young HIV-
infected U.S. adults, a FRAX score ≥ 3%, low baseline BMD, history of prior fracture, 
and increased age were significantly associated with elevated risk of new fracture.
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objeCtives: Clinicians need a reliable, non-invasive predictor of future liver-related 
events with which to monitor disease progress and alert untreated patients to start 
therapy before treatment effectiveness is compromised. This study documents the 
impact of FIB-4 > 3.25 [probable fibrosis] on mortality risk and evaluates if treat-
ment effectiveness is compromised if initiated after fibrosis is detected. Methods: 
Data from a large sample of U.S. veterans were selected using the Veterans 
Administration’s HCV clinical registry [CCR] which compiles patients EMR data from 
1999 to present. Selection criteria required data on viral genotype and sufficient 
laboratory data with which to calculate FIB-4 scores. Time to death was analyzed 
with Cox proportional hazards models using treatment before/after FIB-4 > 3.25, age, 
genotype, gender, race, diabetes and other patient characteristics as independent 
risk factors. Results: 150,958 out of 360,857 unique HCV CCR patients met study 
inclusion criteria. Patients with FIB-4 > 3.25 experienced a 4-fold increase in the 
risk of death [H.R.= 4.23 (4.08-4.38)]. Initiating treatment significantly reduced this 
risk 25% both before the development of fibrosis [H.R.= 0.748 (0.70-0.78) and after 
[H.R.= 0.7537 (0.71-0.81)][p= 0.6896 for the difference]. ConClusions: A FIB-4 score 
> 3.25 is a strong predictor of mortality risk in patients with HCV and the effective-
ness of treatment is not adversely impacted once patients cross this threshold for 
monitoring fibrosis. While our results may under-estimate treatment effectiveness 
if treatment initiation is correlated with illness severity, an FIB-4 > 3.25 can be used 
to motivate patients to initiate treatment before effectiveness in impaired.
PIN22
saFetY oF azItHromYcIN tHeraPY IN PatIeNts wItH HIgH 
cardIovascular rIsk: a meta-aNalYsIs oF raNdomIzed coNtrolled 
trIals
Almalki Z.S.1, Guo J.J.2, Welge J.A.2
1University of Cincinnati College of Pharmacy, Cincinnati, OH, USA, 2University of Cincinnati, 
Cincinnati, OH, USA
of being infected with HBV than other age groups. Stratified by race, Asian patients 
were more likely to be diagnosed with HBV. In addition, female patients residing in 
the Northeast were at higher risk for an HBV diagnosis.
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objeCtives: CA-MRSA has become increasingly common; however, clinical character-
istics and outcomes differentiating CA-MRSA from CA-MSSA are unclear. We compared 
long-term outcomes of adults with CA-MRSA to those with CA-MSSA. Methods: This 
was a prospective, observational study in 13 primary care clinics within the South 
Texas Ambulatory Research Network (STARNet). Classification of MRSA and MSSA, 
and antibiotic susceptibility were determined using the Vitek System (bioMérieux). 
Treatment failure was defined as one of the following within 90 days of the initial visit: 
(1) change in antibiotic therapy, (2) incision and drainage (I&D), (3) SSTI at a new site, (4) 
SSTI at the same site, (5) emergency department visit, or (6) hospitalization. Patients 
were considered to have “moderate or complicated” SSTIs if they had a lesion ≥ 5 cm 
in diameter or diabetes mellitus. Comparisons between groups were performed using 
the χ 2 test and Student’s t test, as appropriate. Results: Among 104 patients with 
community-associated Staphylococcus aureus SSTIs, the overall treatment failure rate 
at 90 days was 20%. The occurrence of treatment failure was similar among patients 
with CA-MRSA infections and those with CA-MSSA infections (13 of 68 [19%] vs. 8 of 36 
[22%] patients; P= 0.71). No significant differences were found in patient demographics, 
clinical characteristics including infection severity and treatment approach, or type 
of treatment failure. Patients with moderate or complicated SSTIs (P= 0.03), and those 
who described signs and symptoms of infection for > 7 days prior to initial clinic 
visit (P= 0.02), were associated with treatment failure. ConClusions: Although it is 
believed that patients with CA-MRSA SSTIs may have more serious outcomes than 
CA-MSSA SSTIs, we found similar outcomes in these two groups in the primary care 
setting. Treatment failures were associated with infection severity and duration of 
infection for seven days or longer prior to seeking care.
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objeCtives: Although the prevalence of low bone mineral density (BMD) and bone 
fractures are increased among HIV-infected adults compared with the general popu-
lation, no study has yet characterized their causal association in the context of HIV 
infection. Methods: We analyzed available dual energy X-ray absorptiometry (DEXA) 
values of the hip (left femoral neck) and clinical data collected prospectively during 
2004-2012 from two CDC-sponsored HIV cohort studies, the HOPS and the SUN Study. 
We assessed factors associated with low BMD (osteopenia or osteoporosis, defined 
by T-scores of -1.0 to > -2.5, and ≤ -2.5, respectively), using the Jochkheere-Terpstra 
test for ordered alternatives for continuous variables and the Cochran-Armitage test 
for categorical variables. We analyzed the association of low BMD with subsequent 
incident fractures using Cox proportional hazards regression. Results: Among 1008 
patients (median age 42 [interquartile range (IQR)35-48] years, 83% male, 67% non-
Hispanic white, median CD4+ cell count [CD4] 408 cells/mm3 [IQR 254-598]), 36.3% 
(n= 366) had osteopenia and 2.9% (n= 29) osteoporosis. During 5,032 person-years of 
observation after DEXA scanning, 95 incident fractures occurred, predominantly rib/
sternum (n= 18), hand (n= 17), foot (n= 15) and wrist (n= 11). Low BMD was significantly 
(p< 0.05) associated with age, lower nadir CD4, history of fracture, and male-male sex 
HIV transmission risk. In unadjusted analyses, age, current or prior tobacco smoking, 
hepatitis C co-infection, history of fracture, and low BMD (osteopenia or osteoporosis) 
were significantly associated with increased hazard of new fracture. In multivariable 
analyses, only osteoporosis (adjusted hazard ratio [aHR] 3.04, 95% confidence interval 
[CI] 1.47-6.30) and age (aHR 1.35 per 10 years, 95% CI 1.07-1.70) remained associated 
with incident fracture. ConClusions: In a large convenience sample of relatively 
young HIV-infected adults in the U.S., low baseline BMD and increasing age were 
strongly associated with elevated risk of incident fracture, highlighting the potential 
value of DEXA screening in this population.
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objeCtives: Surgical site infections (SSIs) are common complications following sur-
gery that can extend patients’ hospital stay and increase hospital costs, the risk of 
morbidity, mortality and of intensive care treatment. Due to the high emergence of 
resistant bacteria, more attention is required preoperatively and intraoperatively to 
prevent SSIs. The objective of the study was to develop a simple tool that quantifies 
the risk of SSI. Methods: The data for this study were obtained from the National 
Surgical Quality Improvement Program (NSQIP) database at the Jewish General 
Hospital (JGH) in Montreal. The sample included patients undergoing surgery between 
November 2009 and December 2011. Bivariate analyses and stepwise multivariate 
logistic regression were used to identify risk factors that were independently associ-
